1. Opioid reduction in ambulatory thyroid and parathyroid surgery after implementing enhanced recovery after surgery protocol
- Author
-
Mikayla Troughton, Tyler Merrill, Riley C. Lide, Mauricio Moreno, Blake Hollowoa, Alexa Robbins, Meghan N. Breckling, Gray M. Orman, Jessica Yeh, Erin Weatherford Creighton, Emre Vural, and Brendan C. Stack
- Subjects
Thyroid Gland ,03 medical and health sciences ,0302 clinical medicine ,030202 anesthesiology ,Humans ,Pain Management ,Medicine ,030212 general & internal medicine ,Retrospective Studies ,Pain, Postoperative ,business.industry ,Thyroid ,Ibuprofen ,Acetaminophen ,Analgesics, Opioid ,medicine.anatomical_structure ,Otorhinolaryngology ,Opioid ,Anesthesia ,Ambulatory ,Morphine ,Premedication ,Enhanced Recovery After Surgery ,business ,medicine.drug ,Patient education - Abstract
BACKGROUND Opioid abuse is widespread in the United States and the risk for chronic use is increased in surgical patients, including patients with thyroid and parathyroid. METHODS Records for 171 patients prior to and 67 patients following implementation of an enhanced recovery after surgery (ERAS) protocol for ambulatory thyroid/parathyroid surgeries were reviewed. The ERAS included superficial cervical plexus block, multimodal premedication, and postoperative reliance on acetaminophen and ibuprofen with judicious prescribing of opioids. RESULTS Post-ERAS patients were prescribed a mean 72 morphine milligram equivalents (MME); pre-ERAS patients were prescribed a mean 163 MME (p
- Published
- 2021